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Letters to the EditorReply to the Editor:
We appreciate the comments of Bottio
and colleagues on our recent report of
intraoperative failure involving 4 bovine
pericardial mitral prostheses.1 The corre-
spondents point out that Carpentier-Ed-
wards Perimount bioprostheses require
physiologic pressure to overcome the in-
herent limited leaflet coaptation that re-
sults from no-pressure fixation. They fur-
ther comment that had the valves in our
report been subjected to more physio-
logic hemodynamics, they might have
demonstrated normal function.
To correct any misunderstanding, we
would note that 2 of the valve failures were
demonstrated after separating from cardio-
pulmonary bypass with acceptable hemo-
dynamics. At physiologic pressures, there
was still massive incompetence, as demon-
strated by means of transesophageal echo-
cardiography. The other 2 failed valves
were tested before atrial closure. In each of
these cases, the degree of insufficiency ob-
served by the surgeons was extremely se-
vere and far greater than that associated
with incomplete closure of a pericardial
valve at low pressures, a phenomenon with
which we are quite familiar.
Paul C. Saunders, MD
Eugene Grossi, MD
Department of Surgery
New York University Medical Center
New York, NY 10016
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Letter to the Editor
Moderate mitral regurgitation repair
at the time of coronary bypass:
When is it required?
To the Editor:
We read with great interest the article
recently published in the Journal by Mal-
lidi and colleagues1 concerning the de-
bated dilemma of whether to treat mild-
to-moderate mitral regurgitation (MR) at
the time of coronary artery bypass graft-
ing (CABG).
The authors studied a consecutive series
of 163 patients with mild-to-moderate MR
796 The Journal of Thoracic and Cardiovaundergoing isolated CABG matched 1:2 with
326 patients without MR undergoing the
same operation. Several preoperative vari-
ables were considered for matching. Among
them, the extent of coronary disease, left ven-
tricular (LV) ejection fraction, functional
New York Heart Association class, and re-
cent myocardial infarction were the specific
variables. The authors report that patients
with MR had poor event-free survival and
worse late functional status at follow-up.
They conclude that “consideration should be
given to repairing moderate MR to improve
long-term quality of life.”
This is a very interesting topic, about
which there is conflicting evidence in the
literature. The importance of the cardiac
variables chosen by the authors for
matching the 2 groups of patients is out
of discussion, but in our opinion the in-
creasing attention on LV volume as a
prognostic indicator after infarction and
CABG should be taken into consider-
ation. LV volume is often unreported in
articles concerning CABG in ischemic
cardiomyopathy, even if it seems now
clear that LV enlargement is far more
predictive of postoperative outcome2,3
and determines the ultimate prognosis.4,5
Yet it cannot be ignored that there is not
necessarily correspondence between low
EF and LV volumes. The authors report
that 44.5% of patients had poor preoper-
ative LV function (40%); at late fol-
low-up, 20% of patients in the MR group
were in New York Heart Association
functional class III/IV; and in a subset of
49 patients with echocardiographic late
evaluation, one third had worsening of
the MR. It would be very interesting to
know the preoperative, as well as the late,
LV volume in all of these subgroups of
patients. Probably a subgroup requiring
mitral valve repair would be recognized.
We fully agree with Mallidi and col-
leagues1 that at the time of CABG, the
“finding of mild to moderate MR should
not be treated as an incidental finding but
should be further evaluated.” We also
support that an accurate and complete
evaluation is mandatory, but one point
should be kept in mind: more important
than MR grade itself is the LV morpho-
functional status, which should guide the
surgical indications and the choice of the
best treatment. As Steven Bolling is
wont to say: “ischemic mitral regurgita-
scular Surgery ● November 2004tion is a ventricular disease, not a valvu-
lar disease.”
Pino Fundarò, MD
Paolo Tartara, MD
Ettore Vitali, MD
Ospedale Niguarda Ca’Granda
Dipartimento Cardiotoracovascolare A. De
Gasperis
Unità Operativa di Cardiochirurgia
Milan, Italy
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Reply to the Editor:
We agree with Drs Fundarò, Tartara, and
Vitali that ischemic mitral regurgitation
(MR) is a disease process with many un-
answered questions regarding its ideal
treatment. The purpose of our study was to
determine the clinical outcomes of patients
treated with isolated coronary artery bypass
grafting who also had mild-to-moderate
MR on a preoperative ventriculogram.1
When compared with a similar cohort with-
out preoperative MR, our data revealed
similar late survival but worse event-free
survival and late functional status for those
patients with preoperative MR. In those
patients with both preoperative and postop-
erative echocardiograms, approximately
one third demonstrated worsening MR.
However, ventriculography alone is inade-
quate to properly assess MR preopera-
Letters to the Editortively, and although the issue of left ven-
tricular volume as a predictor of late
outcome is intriguing, our data do not al-
low us to answer this question. Thus fur-
ther studies are need to be performed to
address the important questions of when
and how to treat MR in similar patients.
In deciding on the appropriate manage-
ment of ischemic MR, we believe it is im-
portant to address both valve-related factors,
such as regurgitant fraction, volume of regur-
gitation, and pattern of regurgitation, as well
as left ventricular factors.2 These factors in-
clude not only the left ventricular end-dia-
stolic volume but also the presence of any
significant left ventricular regional wall-mo-
tion abnormalities.3 We also agree with
Steven Bolling that “ischemic mitral regurgi-
tation is a ventricular disease.” It will be
necessary to understand how these factors
might change over time, especially when
subjected to various medical or surgical treat-
ments, to determine the appropriate point at
which one should intervene with these pa-
tients. Specifically, is surgical revasculariza-
tion of the inferior wall sufficient for patients
with mild-to-moderate MR? Can preopera-
tive factors, such as myocardial viability and
left ventricular volume, help in predicting
who will need a repair and who will not?
Future studies are clearly needed, especially
those investigating the mechanism of isch-
emic MR, that will hopefully yield useful
information with respect to the role of these
factors on the outcomes of patients with isch-
emic MR.
Hari R. Mallidi, MD
Marc P. Pelletier, MD
Department of Cardiac Surgery
University of Toronto
Toronto, Ontario, Canada
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TGuidelines for coronary
revascularization revisited?
A note of caution
To the Editor:
We read with interest the somewhat novel
strategy for coronary bypass described by
Dr Nez˘ic´ and associates.1 The authors sug-
gest that in the case of a localized stenosis
in the mid-to-distal left anterior descending
(LAD) coronary artery, the lesion can be
bypassed with a coronary-coronary graft by
using the distal portion of the left internal
thoracic artery (LITA), thus reducing the
length of conduit used; they also speculate
that this attitude might be particularly use-
ful in younger patients to preserve graft
material for future reoperations. More spe-
cifically, the patient described (41 years
old) underwent LAD-LAD grafting by us-
ing the free distal LITA segment, LITA–
ramus intermedius grafting with the pedi-
cled proximal LITA, and saphenous vein
grafting to the posterior descending artery.
Although the immediate postoperative an-
giographic result is neat, we are quite skep-
tical toward this approach for several rea-
sons.
First, standard LITA-LAD bypass rep-
resents a milestone not only in cardiac sur-
gery but also in medicine in general and
has clearly been shown to improve survival
and reduce the incidence of adverse events
after coronary operations.2,3 Favor toward
bilateral and, more rarely, sequential inter-
nal thoracic artery (ITA) grafting, espe-
cially to the left coronary system in
younger patients, has also increased for
similar reasons.4
Second, coronary-coronary bypass im-
plies 2 arteriotomies and 2 anastomoses to
revascularize the diseased branch. Further-
more, the technique refers to the use of the
distal portion of the LITA to construct the
graft. Not only the caliber is reduced but
also the properties of the distal ITA are
different (more muscular and less elastic
media).5 All these aspects are likely to in-
crease technical hazards of an otherwise
standardized procedure. Also, crossclamp
and bypass times are increased.
Third, if arteriosclerosis involves the
mid-to-distal LAD in a young patient, the
disease is by definition aggressive. It is
thus incorrect to revascularize the distal
LAD depending on its proximal course as
an inflow, because disease is likely to
progress with time. This is clearly exem-
plified by the natural history of bypass
he Journal of Thoracic and Cardiovasculargrafts to the main course of the right cor-
onary artery, which often becomes dis-
eased, especially at the crux.4 In other
words anastomoses should ideally be con-
structed to bypass the most distal lesions.
Also, the arteriotomy and manipulation of
the LAD proximal to the stenosis might
accelerate or promote medial reactivity and
thickening in coronary arteries prone to
arteriosclerosis, whereas the resistance of
the ITA to the development of future ste-
noses is well known.
Fourth, the unsuitability of the patient
for percutaneous coronary angioplasty, as
stated by the authors, is questionable. The
patient showed multivessel disease, but the
presence of an isolated stenosis in the mid-
to-distal LAD might make this option ap-
pealing, if not preferable, especially for
first-time revascularization in younger pa-
tients.
In conclusion, although coronary-coro-
nary bypass might at times be useful, we
advocate caution toward its application to the
LAD. Among the current guidelines for cor-
onary revascularization, the pedicled LITA-
LAD graft represents a gold standard, and
there must be strong reasons (eg, deep in-
tramyocardial LAD and some ventricular an-
eurysm resections or reoperations) not to
construct this graft in coronary operations.
Marco Pocar, MD, PhD
Andrea Moneta, MD
Francesco Donatelli, MD
Cattedra di Cardiochirurgia
Università degli Studi di Milano
Policlinico MultiMedica
Milan, Italy
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